Explore the Influx Healthtech IPO
The global nutraceutical space is worth nearly $400 billion today, blending food, pharma, and biotech into one fast-growing industry. India has a strong edge in this sector due to its roots in Ayurveda and a growing wellness-focused market.
Now, Influx Healthtech Limited is stepping into the spotlight with its upcoming IPO. With Rareever Financial Advisors managing the issue and Maashitla Securities as the registrar, the company is ready to go public and tap into the next phase of growth.
For more information, you can refer to the Influx Healthtech Ltd DRHP.
Note: For 50% of the shares, the anchor lock-in period expires 30 days following the actual allocation, and for the remaining part, it ends 90 days later.
Influx Healthtech IPO: Company Profile
Check these details about the company before you get its Influx Healthtech IPO GMP price. Also, see the Influx Healthtech products list.
Particulars | Details |
Established | 2020 |
Registered Office | Mumbai, Maharashtra |
Products | Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, Homecare Products, Active Pharmaceutical Ingredients (APIs) |
Promoter | Mr. Munir Abdul Ganee Chandniwala |
Awards | Best Sports Supplement Manufacturing Company, Innovative Nutraceuticals of the Year, and Best Nutraceutical Company of the Year 2015 award from CIMS Medica. |
Competitors | Chandan Healthcare Ltd., Aatmaj Healthcare Ltd., Birla Pacific Medspa Ltd., and Biowin Pharma (India) Ltd. |
Exploring the Influx Healthtech Limited IPO
Let’s explore the key highlights of the Influx Healthtech IPO details.
Influx Healthtech IPO Date
Track these milestones and get the Influx Healthtech IPO review.
Particulars | Date |
Listing date | 25 Jun 2025 |
Refund initiation | Jun 24, 2025 |
Mandate end date | 05 July 2025 |
Lock-in end date for anchor investors (50%) | 23 July 2025 |
Issue close date | 20 June 2025 |
Share credit | 24 June 2025 |
UPI mandate deadline | 20 June 2025 (5 PM) |
Allotment finalisation | 23 June 2025 |
Lock-in end date for anchor investors (remaining) | 21 Sep 2025 |
Issue open date | 18 June 2025 |
Influx Healthtech Ltd IPO size
Are you curious about how much they’re aiming to raise? Check the details of Influx Healthtech Limited IPO here.
Particulars | Number of Equity Shares | Aggregate Value (₹ crores) |
Fresh Issue | 50,00,400 | ₹48 crores |
Offer for Sale | 11,00,400 | ₹10.56 crores |
Overall Issue | — | ₹58.57 crores |
Here's what Influx Healthtech Limited will do with the raised capital.
Utilisation Head | Amount (INR crores) |
Setting up a manufacturing unit for Nutraceutical products | 22.60 (47%) |
Corporate needs and general business purposes | 11.05 (23%) |
Establishment of Veterinary Food Production Facility | 11.59 (24%) |
Equipment purchase for the cosmetic and homecare segments | 2.76 (5.75%) |
Other takeaways from the Influx Healthtech share price
Let’s take a closer look at the Influx Healthtech Limited IPO price.
Particulars | Description |
Face value of each share | ₹10 |
Price Range | ₹90 – ₹96 |
Categorisation of different investors
From retail to QIBs, this is how different categories of investors can participate in the Influx Healthtech Limited IPO.
Category | Shares Offered | % of Offer | Min Bid Size | Max Bid Size |
Market Maker | Not Disclosed | Not Disclosed | Not Disclosed | Not Disclosed |
QIBs | Not Disclosed | Up to 50% of Net Offer | Above ₹2,00,000 | Subject to the Net Offer limit |
Non-Institutional Investors | Not Disclosed | At least 15% of Net Offer | Above ₹2,00,000 | Not exceeding Net Offer (excl. QIB) |
Retail Investors | Not Disclosed | At least 35% of Net Offer | Not Disclosed | Up to ₹2,00,000 |
After the allotment is done, your shares will directly reflect in your demat account. Don’t have one yet? This might be the right time to explore top brokers in India who can help you get started.
Also, you can track the Influx Healthtech Limited GMP. Once it hits the market, you must keep an eye on how the share price performs on the exchange.
Influx Healthtech Limited IPO details: Key Financials
Before you invest, check out how Influx Healthtech Limited has performed in the past.
Metrics | Nov 30, 2024 | FY 2023–24 | FY 2022–23 | FY 2021–22 |
Exports Revenue (% of Ops Revenue) | 0.73% | 0.26% | 0.03% | 0.03% |
Foreign Exchange Gain / (Loss) (₹ crores) | -0.41 | 0.07 | - | - |
Cost of Goods (% of Ops Revenue) | 73.79% | 75.96% | 79.66% | 84.47% |
Return on Capital Employed (ROCE) | 34.31% | 65.43% | 78.88% | 120.39% |
Return on Equity (ROE) | 26.02% | 49.06% | 61.76% | 99.54% |
Net Working Capital Cycle (Days) | 49 | 29 | 18 | 6 |
Debt-Equity Ratio | 0.01 | 0.01 | 0.06 | 0.13 |
Fixed Asset Turnover (Times) | 3.87 | 7.28 | 12.02 | 21.60 |
Key Financial Ratios & Metrics
Particulars | Nov 30, 2024 | FY 2023–24 | FY 2022–23 | FY 2021–22 |
EBITDA (₹ in lakhs) | 1,187.00 | 1,687.38 | 1,072.26 | 616.97 |
EPS (₹) – Actual Share Count | 4.43 | 4,488.31 | 2,878.54 | 1,773.81 |
EPS (₹) – Adjusted for Bonus | 4.43 | 6.18 | 3.96 | 2.44 |
Return on Net Worth (%) | 26.02% | 49.06% | 61.76% | 99.54% |
Net Asset Value per Share (₹) – Actual Share Count | 17.03 | 9,148.90 | 4,660.59 | 1,782.06 |
NAV per Share (₹) – Adjusted for Bonus | 17.03 | 12.60 | 6.42 | 2.45 |
Strengths and risks
Before you look up your allotment status, see the major strengths and risks of Influx Healthtech Limited IPO.
Strengths
The company works on everything from wellness to Ayurveda to nutrition.
Keeps quality tight with FDA approvals, ISO badges, and solid safety checks.
Makes custom products for clients in cosmetics, health supplements, and even pet care.
It has its team that tests and fine-tunes products.
Risks
Operations are concentrated in Palghar, and this makes the business sensitive to regional issues.
A few major customers contribute nearly half the revenue.
No long-term deals with top suppliers add risk to cost and supply stability.
Heavy dependence on the nutraceutical segment may impact growth if industry trends shift unexpectedly.
Should you apply for the Influx Healthtech Limited IPO?
Influx Healthtech Limited is preparing to go public with its IPO. The company has been active in healthtech, producing veterinary feed supplements, nutritional supplements, homecare, cosmetics, ayurvedic products, finished dosage forms, and more. This IPO marks a new chapter as Influx Healthtech Limited aims to scale up and take on more opportunities. You can check the Influx Healthtech IPO GMP in the news.
Interested in applying for the Influx Healthtech Limited IPO? Click here to get started.
